ClearPoint Neuro WKN: A2PZ3E ISIN: US18507C1036 Kürzel: CLPT Forum: Aktien Thema: Hauptdiskussion

https://www.it-boltwise.de/clearpoint-neuro-aktie-nach-gewinnverfehlung-unter-druck-strategie-bleibt.html

https://goldesel.de/aktien/news/clearpoint-neuro-steigt-um-32-nach-uniqure-fda-akzeptiert-amt-130-bla-daten-fur-huntington

https://www.accessnewswire.com/newsroom/en/biotechnology/clearpoint-neuro-reports-fourth-quarter-and-full-year-2025-results-1148642

https://uk.investing.com/news/stock-market-news/clearpoint-neuro-stock-rises-after-receiving-eu-mdr-certification-93CH-4468139

🍀

https://ir.clearpointneuro.com/news-events/press-releases/detail/1139/clearpoint-neuro-announces-promising-results-from-brain

https://www.accessnewswire.com/newsroom/en/biotechnology/clearpoint-neuro-announces-expanded-international-clearances-for-key-therapy-delivery-1083409

https://www.tipranks.com/news/why-is-clearpoint-neuro-stock-clpt-up-today ClearPoint Neuro stock soared on Friday alongside new filings with the Securities and Exchange Commission (SEC). In these filings, the company revealed new insider buying from three members of the company’s Board of Directors. Let’s see how many shares of ClearPoint Neuro stock these insiders bought. • Director Timothy Richards purchased 555 shares of CLPT stock for an average price of $21.79 each and now directly owns 78,870 shares. • Director Pascal Girin bought 315 shares of CLPT stock for an average price of $21.79 each and now directly owns 96,949 shares. • Director John Fletcher acquired 265 shares of CLPT stock for an average price of $21.79 each and now directly owns 116,240 shares. ...

https://ir.clearpointneuro.com/news-events/press-releases/detail/1137/clearpoint-neuro-announces-development-and-demonstration-of

https://www.morningstar.com/news/marketwatch/20250924229/heres-why-biotech-uniqures-stock-just-tripled-and-brought-clearpoint-shares-up-with-it

😁

🍀

https://ir.clearpointneuro.com/news-events/press-releases/detail/1131/clearpoint-neuro-reports-first-quarter-2025-results

https://www.stocktitan.net/news/CLPT/clear-point-neuro-reports-fourth-quarter-and-full-year-2024-hmpf4p7toomb.html

https://www.accessnewswire.com/newsroom/en/biotechnology/clearpoint-neuro-announces-eu-mdr-certification-for-the-smartflow-cannula-984263

https://ir.clearpointneuro.com/news-events/press-releases/detail/1123/clearpoint-neuro-announces-fda-clearance-for-clearpoint